186 related articles for article (PubMed ID: 20470772)
21. Sarcoplasmic reticulum genes are selectively down-regulated in cardiomyopathy produced by doxorubicin in rabbits.
Arai M; Tomaru K; Takizawa T; Sekiguchi K; Yokoyama T; Suzuki T; Nagai R
J Mol Cell Cardiol; 1998 Feb; 30(2):243-54. PubMed ID: 9515001
[TBL] [Abstract][Full Text] [Related]
22. Cardioprotective roles of aged garlic extract, grape seed proanthocyanidin, and hazelnut on doxorubicin-induced cardiotoxicity.
Demirkaya E; Avci A; Kesik V; Karslioglu Y; Oztas E; Kismet E; Gokcay E; Durak I; Koseoglu V
Can J Physiol Pharmacol; 2009 Aug; 87(8):633-40. PubMed ID: 19767888
[TBL] [Abstract][Full Text] [Related]
23. Metabolic remodeling associated with subchronic doxorubicin cardiomyopathy.
Carvalho RA; Sousa RP; Cadete VJ; Lopaschuk GD; Palmeira CM; Bjork JA; Wallace KB
Toxicology; 2010 Apr; 270(2-3):92-8. PubMed ID: 20132857
[TBL] [Abstract][Full Text] [Related]
24. Regulation of testis-specific carnitine transporter (octn3) gene by proximal cis-acting elements Sp1 in mice.
Maeda T; Hirayama M; Kobayashi D; Tamai I
Biochem Pharmacol; 2005 Sep; 70(6):858-68. PubMed ID: 16051193
[TBL] [Abstract][Full Text] [Related]
25. Studies on functional sites of organic cation/carnitine transporter OCTN2 (SLC22A5) using a Ser467Cys mutant protein.
Ohashi R; Tamai I; Inano A; Katsura M; Sai Y; Nezu J; Tsuji A
J Pharmacol Exp Ther; 2002 Sep; 302(3):1286-94. PubMed ID: 12183691
[TBL] [Abstract][Full Text] [Related]
26. Carnitine/organic cation transporter OCTN2-mediated transport of carnitine in primary-cultured epididymal epithelial cells.
Kobayashi D; Irokawa M; Maeda T; Tsuji A; Tamai I
Reproduction; 2005 Dec; 130(6):931-7. PubMed ID: 16322553
[TBL] [Abstract][Full Text] [Related]
27. Functional genetic diversity in the high-affinity carnitine transporter OCTN2 (SLC22A5).
Urban TJ; Gallagher RC; Brown C; Castro RA; Lagpacan LL; Brett CM; Taylor TR; Carlson EJ; Ferrin TE; Burchard EG; Packman S; Giacomini KM
Mol Pharmacol; 2006 Nov; 70(5):1602-11. PubMed ID: 16931768
[TBL] [Abstract][Full Text] [Related]
28. Acute doxorubicin cardiotoxicity alters cardiac cytochrome P450 expression and arachidonic acid metabolism in rats.
Zordoky BN; Anwar-Mohamed A; Aboutabl ME; El-Kadi AO
Toxicol Appl Pharmacol; 2010 Jan; 242(1):38-46. PubMed ID: 19796650
[TBL] [Abstract][Full Text] [Related]
29. Effect of verapamil on doxorubicin cardiotoxicity: altered muscle gene expression in cultured neonatal rat cardiomyocytes.
Akimoto H; Bruno NA; Slate DL; Billingham ME; Torti SV; Torti FM
Cancer Res; 1993 Oct; 53(19):4658-64. PubMed ID: 8402643
[TBL] [Abstract][Full Text] [Related]
30. Acute doxorubicin cardiotoxicity involves cardiomyocyte apoptosis.
Arola OJ; Saraste A; Pulkki K; Kallajoki M; Parvinen M; Voipio-Pulkki LM
Cancer Res; 2000 Apr; 60(7):1789-92. PubMed ID: 10766158
[TBL] [Abstract][Full Text] [Related]
31. Nitric oxide and oxidative stress in brain and heart of normal rats treated with doxorubicin: role of aminoguanidine.
Abd El-Gawad HM; El-Sawalhi MM
J Biochem Mol Toxicol; 2004; 18(2):69-77. PubMed ID: 15122648
[TBL] [Abstract][Full Text] [Related]
32. Protection against doxorubicin cardiomyopathy in rats: role of phosphodiesterase inhibitors type 4.
Mohamed HE; Asker ME; Ali SI; el-Fattah TM
J Pharm Pharmacol; 2004 Jun; 56(6):757-68. PubMed ID: 15231041
[TBL] [Abstract][Full Text] [Related]
33. Cloning and functional characterization of a novel up-regulator, cartregulin, of carnitine transporter, OCTN2.
Nagai K; Takikawa O; Kawakami N; Fukao M; Soma T; Oda A; Nishiya T; Hayashi M; Lu L; Nakano M; Kajita E; Fujita H; Miwa S
Arch Biochem Biophys; 2006 Aug; 452(1):29-37. PubMed ID: 16839516
[TBL] [Abstract][Full Text] [Related]
34. Oxidative stress and myocardial gene alterations associated with Doxorubicin-induced cardiotoxicity in rats persist for 2 months after treatment cessation.
Richard C; Ghibu S; Delemasure-Chalumeau S; Guilland JC; Des Rosiers C; Zeller M; Cottin Y; Rochette L; Vergely C
J Pharmacol Exp Ther; 2011 Dec; 339(3):807-14. PubMed ID: 21934029
[TBL] [Abstract][Full Text] [Related]
35. Alcoholic liver injury in the rat is associated with reduced expression of peroxisome proliferator-alpha (PPARalpha)-regulated genes and is ameliorated by PPARalpha activation.
Nanji AA; Dannenberg AJ; Jokelainen K; Bass NM
J Pharmacol Exp Ther; 2004 Jul; 310(1):417-24. PubMed ID: 15016835
[TBL] [Abstract][Full Text] [Related]
36. Effects of angiotensin-1 converting enzyme inhibition on oxidative stress and bradykinin receptor expression during doxorubicin-induced cardiomyopathy in rats.
Richard C; Lauzier B; Delemasure S; Talbot S; Ghibu S; Collin B; Sénécal J; Menetrier F; Vergely C; Couture R; Rochette L
J Cardiovasc Pharmacol; 2008 Sep; 52(3):278-85. PubMed ID: 18806609
[TBL] [Abstract][Full Text] [Related]
37. Selective inhibition of OCTN2 is more effective than inhibition of gamma-butyrobetaine dioxygenase to decrease the availability of l-carnitine and to reduce myocardial infarct size.
Liepinsh E; Makrecka M; Kuka J; Cirule H; Makarova E; Sevostjanovs E; Grinberga S; Vilskersts R; Lola D; Loza E; Stonans I; Pugovics O; Dambrova M
Pharmacol Res; 2014 Jul; 85():33-8. PubMed ID: 24836867
[TBL] [Abstract][Full Text] [Related]
38. Expression and localization of organic cation/carnitine transporter OCTN2 in Caco-2 cells.
Elimrani I; Lahjouji K; Seidman E; Roy MJ; Mitchell GA; Qureshi I
Am J Physiol Gastrointest Liver Physiol; 2003 May; 284(5):G863-71. PubMed ID: 12684216
[TBL] [Abstract][Full Text] [Related]
39. Diclofenac sodium, a nonselective nonsteroidal anti-inflammatory drug aggravates doxorubicin-induced cardiomyopathy in rats.
Singh BK; Pathan RA; Pillai KK; Haque SE; Dubey K
J Cardiovasc Pharmacol; 2010 Feb; 55(2):139-44. PubMed ID: 19920767
[TBL] [Abstract][Full Text] [Related]
40. L-Carnitine attenuates ifosfamide-induced carnitine deficiency and decreased intramitochondrial CoA-SH in rat kidney tissues.
Sayed-Ahmed MM
J Nephrol; 2011; 24(4):490-8. PubMed ID: 21404227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
